Research Article
Insoles Treated with Bacteria-Killing Nanotechnology Bio-Kil Reduce Bacterial Burden in Diabetic Patients and Healthy Controls
Table 2
Baseline data of diabetic patients and healthy individuals.
| | Diabetes group () | Healthy individual group () |
| Sex category (male/female) | 11/20 | 14/17 | Age (y) | 56.6 ± 13.1 | 28.0 ± 4.5 | History of diabetes (y) | 9.5 ± 6.7 | None | History of diabetic peripheral neuropathy (n/%) | 13 (41.9%) | None | History of peripheral artery disease (n/%) | 4 (12.9%) | None |
|
|